-
EP3579923
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3579923
| EP3579923 - TREATMENT OF ASTHMA WITH CYSTEAMINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.05.2024 Database last updated on 19.10.2024 | |
| Former | Examination is in progress Status updated on 28.10.2022 | ||
| Former | Request for examination was made Status updated on 15.11.2019 | ||
| Former | The international publication has been made Status updated on 18.08.2018 | Most recent event Tooltip | 17.05.2024 | Application deemed to be withdrawn | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states Children's Hospital Medical Center 3333 Burnet Avenue Cincinnati, Ohio 45229-3039 / US | [2019/51] | Inventor(s) | 01 /
HERSHEY, Gurjit, K. 11692 Grandstone Lane Cincinnati, OH 45249 / US | 02 /
BIAGINI-MYERS, Jocelyn 4176 Cannon Gate Drive Cincinnati, OH 45245 / US | 03 /
JI, Hong 11170 Huntwicke Place Blue Ash, OH 45241 / US | 04 /
MARTIN, Lisa, J. 7938 Stillmeadow Drive West Chester, OH 45069 / US | [2019/51] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2019/51] | Cabinet Becker et Associés 25, rue Louis le Grand 75002 Paris / FR | Application number, filing date | 18751836.0 | 07.02.2018 | [2019/51] | WO2018US17183 | Priority number, date | US201762455661P | 07.02.2017 Original published format: US 201762455661 P | US201762579406P | 31.10.2017 Original published format: US 201762579406 P | [2019/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018148254 | Date: | 16.08.2018 | Language: | EN | [2018/33] | Type: | A1 Application with search report | No.: | EP3579923 | Date: | 18.12.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.08.2018 takes the place of the publication of the European patent application. | [2019/51] | Search report(s) | International search report - published on: | US | 16.08.2018 | (Supplementary) European search report - dispatched on: | EP | 16.10.2020 | Classification | IPC: | A61K31/145, A61K45/06, A61P11/06, A61K9/00 | [2020/47] | CPC: |
A61P11/06 (EP,US);
A61K31/145 (EP,US);
A61K31/573 (EP,US);
A61K45/06 (EP);
A61K9/0019 (US);
A61K9/0053 (US)
|
| Former IPC [2019/51] | A61P11/06, A61K31/145, C07C323/25 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/51] | Title | German: | BEHANDLUNG VON ASTHMA MIT CYSTEAMIN | [2019/51] | English: | TREATMENT OF ASTHMA WITH CYSTEAMINE | [2019/51] | French: | TRAITEMENT DE L'ASTHME FAISANT INTERVENIR DE LA CYSTÉAMINE | [2019/51] | Entry into regional phase | 16.08.2019 | National basic fee paid | 16.08.2019 | Search fee paid | 16.08.2019 | Designation fee(s) paid | 16.08.2019 | Examination fee paid | Examination procedure | 16.08.2019 | Examination requested [2019/51] | 12.05.2021 | Amendment by applicant (claims and/or description) | 28.10.2022 | Despatch of a communication from the examining division (Time limit: M06) | 12.04.2023 | Reply to a communication from the examining division | 20.07.2023 | Despatch of a communication from the examining division (Time limit: M06) | 31.01.2024 | Application deemed to be withdrawn, date of legal effect [2024/25] | 21.02.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/25] | Fees paid | Renewal fee | 27.02.2020 | Renewal fee patent year 03 | 25.02.2021 | Renewal fee patent year 04 | 25.02.2022 | Renewal fee patent year 05 | 27.02.2023 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 29.02.2024 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I] - KEUNHEE OH; MYUNG WON SEO; GA YOUNG LEE; OK-JIN BYOUN; HYE-RYUN KANG; SANG-HEON CHO; DONG-SUP LEE, "Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response", RESPIRATORY RESEARCH, (20130313), vol. 14, no. 1, doi:10.1186/1465-9921-14-35, ISSN 1465-9921, page 35, XP021140649 [I] 1-15 * abstract * * page 36, column 1, line 40 - column 2, line 3 * * page 39, column 2, 'Cysteamine treatment reduced recruitment of airway inflammatory cells' * DOI: http://dx.doi.org/10.1186/1465-9921-14-35 | [T] - PAIGE E. BOLCAS ET AL, "Cysteamine prevents asthma development and reduces airway hyperresponsiveness in experimental asthma", ALLERGY, United Kingdom, (20200420), doi:10.1111/all.14332, ISSN 0105-4538, pages 1 - 4, XP055737980 [T] 1-15 * the whole document * DOI: http://dx.doi.org/10.1111/all.14332 | International search | [Y]US2014275279 (EDDY ALLISON A [US], et al) [Y] 18-20* entire document *; | [XY]WO2015175886 (CHILDRENS HOSP MEDICAL CENTER [US]) [X] 1, 2, 5, 6 * entire document * [Y] 3, 4, 18-20; | [Y]US2016207995 (YANSURA DANIEL G [US], et al) [Y] 3, 4 * entire document * |